JENNIFER BARTLEY: Open Payments
NPI 1659852556 · LEBANON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$611 in 26 payments from 11 companies in 2025. Trend: 2023 $342 · 2024 $699 · 2025 $611
Food & beverage: $611
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 6 | $196 |
| Janssen Pharmaceuticals, Inc | 5 | $117 |
| Vanda Pharmaceuticals Inc. | 3 | $82 |
| Biogen, Inc. | 3 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $55 |
| Alkermes, Inc. | 1 | $24 |
| Indivior Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
Products named: Auvelity, INVEGA SUSTENNA, FANAPT, ZURZUVAE, NINLARO, SPRAVATO, LYBALVI, SUBLOCADE.
Industry payments across KY — which companies pay providers there.
